sFRPs, WIF, glypicans, Tiki, and Notum are well-known regulators of Wnt/-catenin signalling that target Wnt proteins to affect signal transduction
There were no cases of bowel obstruction with semaglutide, but the adverse event occurred at an incidence of 8.1 per 1,000 person-years with liraglutide and 1.7 per 1,000 person-years with bupropion-naltrexone
GLP-1 receptor agonists (semaglutide, liraglutide) are not contraindicated with levothyroxine but may affect gastric emptying and medication absorption
Estrogen receptor-mediated and cytotoxic effects of the antiestrogens tamoxifen and 4-hydroxytamoxifen
In addition to reducing inflammation and accelerating recovery from injuries (including sports injuries), BPC-157 can also improve gut health by protecting against ulcers and promoting gastrointestinal healing